chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: red, swollen, and warmth at the injection site; red, swollen, and warmth at the injection site; red, swollen, and warmth at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red, swollen, and warmth at the injection site), VACCINATION SITE SWELLING (red, swollen, and warmth at the injection site) and VACCINATION SITE WARMTH (red, swollen, and warmth at the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     No medical history was provided by reporter.     On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (red, swollen, and warmth at the injection site), VACCINATION SITE SWELLING (red, swollen, and warmth at the injection site) and VACCINATION SITE WARMTH (red, swollen, and warmth at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (red, swollen, and warmth at the injection site), VACCINATION SITE SWELLING (red, swollen, and warmth at the injection site) and VACCINATION SITE WARMTH (red, swollen, and warmth at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose 56 days ago; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 56 days ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 56 days ago). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose 56 days ago) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication provided by the reporter No treatment information reported by the reporter
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Vaccine administered to age less than 18; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to age less than 18) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to age less than 18). On 30-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Vaccine administered to age less than 18) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was reported.   This case was linked to MODERNATX, INC.-MOD-2021-147956 (E2B Linked Report).
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site pain
Clinical narrative: 2x1 red rectangular lesion under the injection site; Painful; "felt tired after but it was nothing"; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE ("felt tired after but it was nothing"), VACCINATION SITE ERYTHEMA (2x1 red rectangular lesion under the injection site) and VACCINATION SITE PAIN (Painful) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 18-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced FATIGUE ("felt tired after but it was nothing"). On 19-May-2021, the patient experienced VACCINATION SITE ERYTHEMA (2x1 red rectangular lesion under the injection site) and VACCINATION SITE PAIN (Painful). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FATIGUE ("felt tired after but it was nothing"), VACCINATION SITE ERYTHEMA (2x1 red rectangular lesion under the injection site) and VACCINATION SITE PAIN (Painful) outcome was unknown.            No concomitant medication information was provided
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash only on left side; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash only on left side) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN 15 and LISINOPRIL for an unknown indication.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (rash only on left side). At the time of the report, RASH (rash only on left side) outcome was unknown.            Patient reported rash only on the left side after receiving the second dose and it lasted for two weeks.  Treatment details included counter cream for rash.     This case was linked to US-MODERNATX, INC.-MOD-2021-148564 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: Follow up received on 09-JUL-2021. No new information.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-148564:crosslinked
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol and Thyroid disorder NOS. Concomitant products included ATORVASTATIN for Cholesterol, LEVOTHYROXINE for Thyroid disorder NOS, VITAMIN D [VITAMIN D NOS], ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Benadryl was taken as treatment medication.   This case was linked to MOD-2021-148714 (Patient Link).
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itchiness; broke out into rash inside bilateral upper thigh; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness) and RASH (broke out into rash inside bilateral upper thigh) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced PRURITUS (itchiness) and RASH (broke out into rash inside bilateral upper thigh). At the time of the report, PRURITUS (itchiness) outcome was unknown and RASH (broke out into rash inside bilateral upper thigh) had resolved.            No concomitant medications were provided.  No treatment information was provided.     This case was linked to MOD-2021-054503 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Follow up received on 16 JUL 2021 contains significant information which includes events and out come of  events .
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Myalgia, Nausea, Pain, Pyrexia
Clinical narrative: General malaise; Generalized pain; Fever 104; Nausea; Vomiting; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (General malaise), PAIN (Generalized pain), MYALGIA (Arm pain), PYREXIA (Fever 104) and NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced MYALGIA (Arm pain). On 19-May-2021, the patient experienced MALAISE (General malaise), PAIN (Generalized pain), PYREXIA (Fever 104), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, MALAISE (General malaise), PAIN (Generalized pain), MYALGIA (Arm pain), PYREXIA (Fever 104), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: General malaise; Generalized pain; Fever 104; Nausea; Vomiting; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (General malaise), PAIN (Generalized pain), MYALGIA (Arm pain), PYREXIA (Fever 104) and NAUSEA (Nausea) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-May-2021, the patient experienced MYALGIA (Arm pain). On 19-May-2021, the patient experienced MALAISE (General malaise), PAIN (Generalized pain), PYREXIA (Fever 104), NAUSEA (Nausea) and VOMITING (Vomiting). At the time of the report, MALAISE (General malaise), PAIN (Generalized pain), MYALGIA (Arm pain), PYREXIA (Fever 104), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Weight increased
Clinical narrative: Dry mouth; Weight gain; This spontaneous case was reported by a patient and describes the occurrence of DRY MOUTH (Dry mouth) and WEIGHT INCREASED (Weight gain) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced DRY MOUTH (Dry mouth) and WEIGHT INCREASED (Weight gain). At the time of the report, DRY MOUTH (Dry mouth) and WEIGHT INCREASED (Weight gain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant  medication and treatment medications were reported. .   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Non-Significant follow up. Contact information updated.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness
Clinical narrative: Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Flu like symptoms, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) had not resolved.            No concomitant medication were provided by the reporter.   This case was linked to MOD-2021-148711 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow up received included no new signification information. Correction made in initial document, processed as second dose case, first dose events removed.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Taste disorder, Vaccination site rash
Clinical narrative: Bad taste on tongue; Vaccination site rash; pain in arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TASTE DISORDER (Bad taste on tongue), PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (Vaccination site rash) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No medical history was provided by reporter.     On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PAIN IN EXTREMITY (pain in arm). On 10-Apr-2021, the patient experienced TASTE DISORDER (Bad taste on tongue) and VACCINATION SITE RASH (Vaccination site rash). The patient was treated with FLUCONAZOLE (THRUSH ORAL CAPSULE) (oral) for Taste disturbance, at an unspecified dose and frequency. At the time of the report, TASTE DISORDER (Bad taste on tongue), PAIN IN EXTREMITY (pain in arm) and VACCINATION SITE RASH (Vaccination site rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant drugs were reported as anxiety medicine.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Vaccination complication, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Patient had side effects from her first dose in her right deltoid.; a lot of shortness of breath; really bad rash in the area where I got the vaccine; It's really swollen, tender; tender; painful when you press on it; itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (Patient had side effects from her first dose in her right deltoid.), DYSPNOEA (a lot of shortness of breath), VACCINATION SITE RASH (really bad rash in the area where I got the vaccine), VACCINATION SITE SWELLING (It's really swollen, tender) and VACCINATION SITE PAIN (tender) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced DYSPNOEA (a lot of shortness of breath), VACCINATION SITE RASH (really bad rash in the area where I got the vaccine), VACCINATION SITE SWELLING (It's really swollen, tender), VACCINATION SITE PAIN (tender), VACCINATION SITE PAIN (painful when you press on it) and VACCINATION SITE PRURITUS (itchy). On an unknown date, the patient experienced VACCINATION COMPLICATION (Patient had side effects from her first dose in her right deltoid.). The patient was treated with HYDROCORTISONE at a dose of 1 dosage form and GRAMICIDIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORINE) at a dose of 1 dosage form. At the time of the report, VACCINATION COMPLICATION (Patient had side effects from her first dose in her right deltoid.), DYSPNOEA (a lot of shortness of breath), VACCINATION SITE RASH (really bad rash in the area where I got the vaccine), VACCINATION SITE SWELLING (It's really swollen, tender), VACCINATION SITE PAIN (tender), VACCINATION SITE PAIN (painful when you press on it) and VACCINATION SITE PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided by the reporter. Treatment medications includes Steroid cream , Hydrocortisone and Neosporin and antibiotics .
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Patient had side effects from her first dose in her right deltoid.; a lot of shortness of breath; really bad rash in the area where I got the vaccine; It's really swollen, tender; tender; painful when you press on it; itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION COMPLICATION (Patient had side effects from her first dose in her right deltoid.), DYSPNOEA (a lot of shortness of breath), VACCINATION SITE RASH (really bad rash in the area where I got the vaccine), VACCINATION SITE SWELLING (It's really swollen, tender) and VACCINATION SITE PAIN (tender) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, the patient experienced DYSPNOEA (a lot of shortness of breath), VACCINATION SITE RASH (really bad rash in the area where I got the vaccine), VACCINATION SITE SWELLING (It's really swollen, tender), VACCINATION SITE PAIN (tender), VACCINATION SITE PAIN (painful when you press on it) and VACCINATION SITE PRURITUS (itchy). On an unknown date, the patient experienced VACCINATION COMPLICATION (Patient had side effects from her first dose in her right deltoid.). The patient was treated with HYDROCORTISONE at a dose of 1 dosage form and GRAMICIDIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORINE) at a dose of 1 dosage form. At the time of the report, VACCINATION COMPLICATION (Patient had side effects from her first dose in her right deltoid.), DYSPNOEA (a lot of shortness of breath), VACCINATION SITE RASH (really bad rash in the area where I got the vaccine), VACCINATION SITE SWELLING (It's really swollen, tender), VACCINATION SITE PAIN (tender), VACCINATION SITE PAIN (painful when you press on it) and VACCINATION SITE PRURITUS (itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were provided by the reporter. Treatment medications includes Steroid cream , Hydrocortisone and Neosporin and antibiotics .
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient missed the 2nd dose beyond recommended window; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient missed the 2nd dose beyond recommended window) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient missed the 2nd dose beyond recommended window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient missed the 2nd dose beyond recommended window) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Bone pain, Dry mouth, Eye swelling
Clinical narrative: mouth was dry with foam in mouth; her hips were killing her; headache/slight headache; she had a fever; feet hurt/arm hurt; nausea; foamy mouth/foam in mouth; spine hurt; ribs hurt; her bones all hurt bad; esophagus dry; eyes swollen; eyes red; face swollen; weak; body felt weird; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry) and DRY MOUTH (mouth was dry with foam in mouth) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced FEELING ABNORMAL (body felt weird). On 18-May-2021, the patient experienced SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry), FOAMING AT MOUTH (foamy mouth/foam in mouth), EYE SWELLING (eyes swollen), OCULAR HYPERAEMIA (eyes red), SWELLING FACE (face swollen), ASTHENIA (weak), MYALGIA (feet hurt/arm hurt), NAUSEA (nausea) and PYREXIA (she had a fever). On 19-May-2021, the patient experienced DRY MOUTH (mouth was dry with foam in mouth), ARTHRALGIA (her hips were killing her) and HEADACHE (headache/slight headache). The patient was treated with LIDOCAINE (topical) on 18-May-2021 for Pain in foot, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) on 18-May-2021 at a dose of 1 dosage form. On 17-May-2021, FEELING ABNORMAL (body felt weird) had resolved. On 19-May-2021, EYE SWELLING (eyes swollen), OCULAR HYPERAEMIA (eyes red), SWELLING FACE (face swollen), ASTHENIA (weak), NAUSEA (nausea) and PYREXIA (she had a fever) had resolved. At the time of the report, SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry), DRY MOUTH (mouth was dry with foam in mouth), FOAMING AT MOUTH (foamy mouth/foam in mouth), ARTHRALGIA (her hips were killing her), MYALGIA (feet hurt/arm hurt) and HEADACHE (headache/slight headache) outcome was unknown.            No concomitant medications were reported Action taken with mRNA-1273 in response to the event was not applicable.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Foaming at mouth, Headache, Musculoskeletal chest pain, Myalgia
Clinical narrative: mouth was dry with foam in mouth; her hips were killing her; headache/slight headache; she had a fever; feet hurt/arm hurt; nausea; foamy mouth/foam in mouth; spine hurt; ribs hurt; her bones all hurt bad; esophagus dry; eyes swollen; eyes red; face swollen; weak; body felt weird; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry) and DRY MOUTH (mouth was dry with foam in mouth) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced FEELING ABNORMAL (body felt weird). On 18-May-2021, the patient experienced SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry), FOAMING AT MOUTH (foamy mouth/foam in mouth), EYE SWELLING (eyes swollen), OCULAR HYPERAEMIA (eyes red), SWELLING FACE (face swollen), ASTHENIA (weak), MYALGIA (feet hurt/arm hurt), NAUSEA (nausea) and PYREXIA (she had a fever). On 19-May-2021, the patient experienced DRY MOUTH (mouth was dry with foam in mouth), ARTHRALGIA (her hips were killing her) and HEADACHE (headache/slight headache). The patient was treated with LIDOCAINE (topical) on 18-May-2021 for Pain in foot, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) on 18-May-2021 at a dose of 1 dosage form. On 17-May-2021, FEELING ABNORMAL (body felt weird) had resolved. On 19-May-2021, EYE SWELLING (eyes swollen), OCULAR HYPERAEMIA (eyes red), SWELLING FACE (face swollen), ASTHENIA (weak), NAUSEA (nausea) and PYREXIA (she had a fever) had resolved. At the time of the report, SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry), DRY MOUTH (mouth was dry with foam in mouth), FOAMING AT MOUTH (foamy mouth/foam in mouth), ARTHRALGIA (her hips were killing her), MYALGIA (feet hurt/arm hurt) and HEADACHE (headache/slight headache) outcome was unknown.            No concomitant medications were reported Action taken with mRNA-1273 in response to the event was not applicable.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Ocular hyperaemia, Oesophageal disorder, Pyrexia, Spinal pain
Clinical narrative: mouth was dry with foam in mouth; her hips were killing her; headache/slight headache; she had a fever; feet hurt/arm hurt; nausea; foamy mouth/foam in mouth; spine hurt; ribs hurt; her bones all hurt bad; esophagus dry; eyes swollen; eyes red; face swollen; weak; body felt weird; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry) and DRY MOUTH (mouth was dry with foam in mouth) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced FEELING ABNORMAL (body felt weird). On 18-May-2021, the patient experienced SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry), FOAMING AT MOUTH (foamy mouth/foam in mouth), EYE SWELLING (eyes swollen), OCULAR HYPERAEMIA (eyes red), SWELLING FACE (face swollen), ASTHENIA (weak), MYALGIA (feet hurt/arm hurt), NAUSEA (nausea) and PYREXIA (she had a fever). On 19-May-2021, the patient experienced DRY MOUTH (mouth was dry with foam in mouth), ARTHRALGIA (her hips were killing her) and HEADACHE (headache/slight headache). The patient was treated with LIDOCAINE (topical) on 18-May-2021 for Pain in foot, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) on 18-May-2021 at a dose of 1 dosage form. On 17-May-2021, FEELING ABNORMAL (body felt weird) had resolved. On 19-May-2021, EYE SWELLING (eyes swollen), OCULAR HYPERAEMIA (eyes red), SWELLING FACE (face swollen), ASTHENIA (weak), NAUSEA (nausea) and PYREXIA (she had a fever) had resolved. At the time of the report, SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry), DRY MOUTH (mouth was dry with foam in mouth), FOAMING AT MOUTH (foamy mouth/foam in mouth), ARTHRALGIA (her hips were killing her), MYALGIA (feet hurt/arm hurt) and HEADACHE (headache/slight headache) outcome was unknown.            No concomitant medications were reported Action taken with mRNA-1273 in response to the event was not applicable.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: mouth was dry with foam in mouth; her hips were killing her; headache/slight headache; she had a fever; feet hurt/arm hurt; nausea; foamy mouth/foam in mouth; spine hurt; ribs hurt; her bones all hurt bad; esophagus dry; eyes swollen; eyes red; face swollen; weak; body felt weird; This spontaneous case was reported by a consumer and describes the occurrence of SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry) and DRY MOUTH (mouth was dry with foam in mouth) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 17-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-May-2021, the patient experienced FEELING ABNORMAL (body felt weird). On 18-May-2021, the patient experienced SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry), FOAMING AT MOUTH (foamy mouth/foam in mouth), EYE SWELLING (eyes swollen), OCULAR HYPERAEMIA (eyes red), SWELLING FACE (face swollen), ASTHENIA (weak), MYALGIA (feet hurt/arm hurt), NAUSEA (nausea) and PYREXIA (she had a fever). On 19-May-2021, the patient experienced DRY MOUTH (mouth was dry with foam in mouth), ARTHRALGIA (her hips were killing her) and HEADACHE (headache/slight headache). The patient was treated with LIDOCAINE (topical) on 18-May-2021 for Pain in foot, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) on 18-May-2021 at a dose of 1 dosage form. On 17-May-2021, FEELING ABNORMAL (body felt weird) had resolved. On 19-May-2021, EYE SWELLING (eyes swollen), OCULAR HYPERAEMIA (eyes red), SWELLING FACE (face swollen), ASTHENIA (weak), NAUSEA (nausea) and PYREXIA (she had a fever) had resolved. At the time of the report, SPINAL PAIN (spine hurt), MUSCULOSKELETAL CHEST PAIN (ribs hurt), BONE PAIN (her bones all hurt bad), OESOPHAGEAL DISORDER (esophagus dry), DRY MOUTH (mouth was dry with foam in mouth), FOAMING AT MOUTH (foamy mouth/foam in mouth), ARTHRALGIA (her hips were killing her), MYALGIA (feet hurt/arm hurt) and HEADACHE (headache/slight headache) outcome was unknown.            No concomitant medications were reported Action taken with mRNA-1273 in response to the event was not applicable.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Feeling hot, Headache, Heavy menstrual bleeding
Clinical narrative: Brought a really heavy period; wake up hot for six weeks; Shortened my menstrual cycle,had an earlier period, came six days earlier; Chest pains; Headache; Being tired; Cold after vaccine; Pain; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier), NASOPHARYNGITIS (Cold after vaccine) and PAIN (Pain) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C11A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold after vaccine), PAIN (Pain), HEADACHE (Headache) and FATIGUE (Being tired). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier) and CHEST PAIN (Chest pains). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier), NASOPHARYNGITIS (Cold after vaccine), PAIN (Pain), CHEST PAIN (Chest pains), HEADACHE (Headache) and FATIGUE (Being tired) outcome was unknown.            Concomitant medications reported as none.   This case was linked to US-MODERNATX, INC.-MOD-2021-149251, US-MODERNATX, INC.-MOD-2021-148821, US-MODERNATX, INC.-MOD-2021-149413, US-MODERNATX, INC.-MOD-2021-149360 (E2B Linked Report). This case was linked to MOD-2021-148424 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Added event - chest pain.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-149413:Cluster case-2nd dose US-MODERNATX, INC.-MOD-2021-149360:Cluster case-1st dose US-MODERNATX, INC.-MOD-2021-148821:Unknown female-1st dose US-MODERNATX, INC.-MOD-2021-149251:Unknown female-2nd dose
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pain, Polymenorrhoea
Clinical narrative: Brought a really heavy period; wake up hot for six weeks; Shortened my menstrual cycle,had an earlier period, came six days earlier; Chest pains; Headache; Being tired; Cold after vaccine; Pain; This spontaneous case was reported by a consumer and describes the occurrence of HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier), NASOPHARYNGITIS (Cold after vaccine) and PAIN (Pain) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025C11A and 037A21B) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced NASOPHARYNGITIS (Cold after vaccine), PAIN (Pain), HEADACHE (Headache) and FATIGUE (Being tired). On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier) and CHEST PAIN (Chest pains). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, HEAVY MENSTRUAL BLEEDING (Brought a really heavy period), FEELING HOT (wake up hot for six weeks), POLYMENORRHOEA (Shortened my menstrual cycle,had an earlier period, came six days earlier), NASOPHARYNGITIS (Cold after vaccine), PAIN (Pain), CHEST PAIN (Chest pains), HEADACHE (Headache) and FATIGUE (Being tired) outcome was unknown.            Concomitant medications reported as none.   This case was linked to US-MODERNATX, INC.-MOD-2021-149251, US-MODERNATX, INC.-MOD-2021-148821, US-MODERNATX, INC.-MOD-2021-149413, US-MODERNATX, INC.-MOD-2021-149360 (E2B Linked Report). This case was linked to MOD-2021-148424 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Added event - chest pain.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-149413:Cluster case-2nd dose US-MODERNATX, INC.-MOD-2021-149360:Cluster case-1st dose US-MODERNATX, INC.-MOD-2021-148821:Unknown female-1st dose US-MODERNATX, INC.-MOD-2021-149251:Unknown female-2nd dose
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Fatigue, Headache, Heart rate increased
Clinical narrative: Joint aching next day after Moderna Covid-19 injection administration; Shortness of breath; fast heart rate twice a day that lasts 10seconds per day; Tiredness; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint aching next day after Moderna Covid-19 injection administration), DYSPNOEA (Shortness of breath), HEART RATE INCREASED (fast heart rate twice a day that lasts 10seconds per day), FATIGUE (Tiredness) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 30-Apr-2021, the patient experienced ARTHRALGIA (Joint aching next day after Moderna Covid-19 injection administration), DYSPNOEA (Shortness of breath), HEART RATE INCREASED (fast heart rate twice a day that lasts 10seconds per day), FATIGUE (Tiredness) and HEADACHE (Headache). At the time of the report, ARTHRALGIA (Joint aching next day after Moderna Covid-19 injection administration), DYSPNOEA (Shortness of breath), HEART RATE INCREASED (fast heart rate twice a day that lasts 10seconds per day), FATIGUE (Tiredness) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication use was unknown Treatment information was unknown
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite
Clinical narrative: lost appetite for 3 days; chills; This spontaneous case was reported by a patient and describes the occurrence of DECREASED APPETITE (lost appetite for 3 days) and CHILLS (chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 002C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-May-2021, the patient experienced DECREASED APPETITE (lost appetite for 3 days) and CHILLS (chills). At the time of the report, DECREASED APPETITE (lost appetite for 3 days) and CHILLS (chills) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medication details was reported. No treatment medication details was reported.    This case was linked to MOD-2021-095595 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthma, Chills, Cough, Dyspnoea
Clinical narrative: asthma symptoms; Wheezing; coughing a lot which is not going away; Shortness of breath; Chills; Joint ache; Body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), ASTHMA (asthma symptoms), WHEEZING (Wheezing), COUGH (coughing a lot which is not going away) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 004C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced CHILLS (Chills), ARTHRALGIA (Joint ache), MYALGIA (Body ache) and HEADACHE (Headache). On 09-May-2021, the patient experienced DYSPNOEA (Shortness of breath), WHEEZING (Wheezing) and COUGH (coughing a lot which is not going away). On an unknown date, the patient experienced ASTHMA (asthma symptoms). On 08-May-2021, CHILLS (Chills), ARTHRALGIA (Joint ache) and MYALGIA (Body ache) had resolved, HEADACHE (Headache) outcome was unknown. At the time of the report, DYSPNOEA (Shortness of breath), ASTHMA (asthma symptoms), WHEEZING (Wheezing) and COUGH (coughing a lot which is not going away) outcome was unknown.            No concomitant medication information was reported. Treatment included cough syrup, home remedies like tea and honey.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Wheezing
Clinical narrative: asthma symptoms; Wheezing; coughing a lot which is not going away; Shortness of breath; Chills; Joint ache; Body ache; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), ASTHMA (asthma symptoms), WHEEZING (Wheezing), COUGH (coughing a lot which is not going away) and CHILLS (Chills) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 004C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-May-2021, the patient experienced CHILLS (Chills), ARTHRALGIA (Joint ache), MYALGIA (Body ache) and HEADACHE (Headache). On 09-May-2021, the patient experienced DYSPNOEA (Shortness of breath), WHEEZING (Wheezing) and COUGH (coughing a lot which is not going away). On an unknown date, the patient experienced ASTHMA (asthma symptoms). On 08-May-2021, CHILLS (Chills), ARTHRALGIA (Joint ache) and MYALGIA (Body ache) had resolved, HEADACHE (Headache) outcome was unknown. At the time of the report, DYSPNOEA (Shortness of breath), ASTHMA (asthma symptoms), WHEEZING (Wheezing) and COUGH (coughing a lot which is not going away) outcome was unknown.            No concomitant medication information was reported. Treatment included cough syrup, home remedies like tea and honey.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: slight itching at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (slight itching at injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 026A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (slight itching at injection site). At the time of the report, VACCINATION SITE PRURITUS (slight itching at injection site) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-064008 (Patient Link).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Cough, Musculoskeletal stiffness, Nasopharyngitis
Clinical narrative: I don't have smell; stiff neck; little cough; cold like symptoms; sore throat; I don't have smell or taste; injection arm bothered little bit; This spontaneous case was reported by a patient and describes the occurrence of MUSCULOSKELETAL STIFFNESS (stiff neck), COUGH (little cough), NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat) and AGEUSIA (I don't have smell or taste) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), OMEPRAZOLE, ALENDRONATE SODIUM (FOSAMAX), COLECALCIFEROL (VITAMIN D3) and CELECOXIB for an unknown indication.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (stiff neck), COUGH (little cough), NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat), AGEUSIA (I don't have smell or taste) and PAIN IN EXTREMITY (injection arm bothered little bit). On an unknown date, the patient experienced ANOSMIA (I don't have smell). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-May-2021, PAIN IN EXTREMITY (injection arm bothered little bit) outcome was unknown. At the time of the report, MUSCULOSKELETAL STIFFNESS (stiff neck), COUGH (little cough), NASOPHARYNGITIS (cold like symptoms), OROPHARYNGEAL PAIN (sore throat), AGEUSIA (I don't have smell or taste) and ANOSMIA (I don't have smell) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The action taken with the drug was not applicable.